Laparoscopic myomectomy and possible risk factors for recurrence
Abstract
Background
The aim of the research was to determine the success of laparoscopic myomectomy (LM), frequency of recurrence of fibroids following the treatment and possible risk factors for recurrence.
Methods
Retrospective research was used. We included 455 females who underwent LM in the period from January 2003 until December 2006 at the Ljubljana Gynaecologic Clinic (Reproduction Clinical Department). The data was collected from the analysis of questionnaires sent to the females in 2010 to their postal addresses.
Results
The questionnaire was completed by 297 (65.3 %) females, 6 questionnaires were excluded from further analysis due to incomplete answers. We analysed 291 questionnaries. The surgery fulfilled expectations of 257 (88.3%) females, uterine bleeding was normalised in 168 cases (85.3 %), pain was reduced or stopped completely in 135 cases (86.5 %). A fibroid recurred in 98 (33.7 %) cases, on average 25.1 (2-96) months after the procedure, 40 (40.8 %) females underwent repeat surgery. As for risk factors for fibroid recurrence following LM, the number of removed fibroids proved to be statistically significant (p = 0.026), while the impact of age was not statistically significant (p = 0.77).
Conclusions
Given that the probability of fibroid recurrence and repeat surgery increases with the number of removed fibroids in the first operation, it may be appropriate for women with multiple fibroids who have completed their fertility period to propose one of the methods of hysterectomy, in particular, are increasingly well-established minimally invasive laparoscopic supracervical or total hysterectomy.
Downloads
References
Wallach EE, Vlahos NF. Uterine myomas: an overview of developmant, clinical features and management. Obstet Gynecol 2004; 104: 393-406.
Adams Hillard PJ. Benign diseases of the female reproductive tract. In: Berek SJ, ed. Berek & Novak,s Gynecology. 14th edition. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 431-496.
Stewart EA. Uterine fibroids. Lancet 2001; 375: 293-8.
Ribič-Pucelj M, Tomaževič T, Vogler A. Laparoskopska miomektomija. In: Ribič-Pucelj M, ed. Endoskopske operacije v ginekologiji. Radovljica: Didakta; 2007. p. 207-215.
Bukulmez O, Doody KJ. Clinical features of myomas. Obstet Gynecol Clin N Am 2006; 33: 69-84.
Buttram V, Reiter R. Uterine leiomyoma-etiology, symptomatology and management. Fertil Steril 1981; 36:433-45.
Nezhat F, Seidman DS, Nezhat C, Nezhat CH. Laparoscopic myomectomy today. Why, when and for whom? Hum Reprod 1996; 11: 933-8.
Olive DL, Lindheim SR, Pritts EA. Conservative surgical management of uterine myomas. Obstet Gynecol Clin N Am 2006; 33: 115-24.
Ribič-Pucelj M. Miomektomija in histerektomija. In. Vogler A, Vrtačnik Bokal E, eds. Nepravilne krvavitve iz maternice v rodnem obdobju. 6. spominski sestanek prof. dr. Lidije Andolšek-Jeras. 2010 november 19.; Ljubljana, Slovenija. Ljubljana: Slovensko društvo za reproduktivno medicino; 2010
Mukhopadhaya N, De Silva C, Manyonda IT. Conventional myomectomy. Best Practice & Research Clin Obstet Gynecol 2008; 22: 677-705.
Agdi M, Tulandi T. Endoscopic management of uterine fibroids. Best Practice & Research Clin Obstet Gynecol 2008; 22: 707-16.
Dubuisson JB, Fauconnier A, Babaki-Fard K, Chapron C. Laparoscopic myomectomy: a current view. Hum Repro Update 2000; 6: 588-94.
Bae JH, Chong GO, Seong WJ, Hong DG, Lee YS. Benefit of uterine artery ligation in laparoscopic myomectomy. Fertil Steril. 2011; 95: 775-8.
Cheng Z, Yang W, Dai H, Hu L, Qu X, Kang L. Laparoscopic uterine artery occlusion combined with myomectomy for uterine myomas. J Min Inv Gynecol. 2008; 15: 346-9.
Alborzi S, Ghannadan E, Alborzi S, Alborzi M. A comparison ob combined laparoscopic uterine artery ligation and myomectomy versus laparoscopic myomectomy in treatment of symptomatoc myoma. Fertil Steril. 2009; 92: 742-7.
Nezhat FR, Roemisch M, Nezhat CH, Seidman DS, Nezhat CR. Recurrence rate after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 1998; 5: 237-40.
Vavala V, Lanzone A, Monaco A, Scribanti A, Guida C, Mancuso S. Postoperative GnRH analog treatment for the prevention of recurrences of uterine myomas after myomectomy. A pilot study. Gynecol Obstet Invest 1997; 43: 251-54.
Fauconnier A, Chapron C, Babaki-Fard K, Dubuisson JB. Recurrence of leiomyomata after myomectomy. Hum Reprod Update 2000; 6: 595-602.
Candiani GB, Fedele L, Parazzini F, Villa L. Risk of recurrence after myomectomy. Br J Obstet Gynecol 1991; 98: 385-9.
Fedele L, Parazzini F, Luchini L, Mezzopane R, Tozzi L, Villa L. Recurrence of fibroids after myomectomy: a tranvaginal ultrasonographic study. Hum Repro 1995; 10: 1795-6.
Brown AB, Chamberlain R, Te Linde RW. Myomectomy. Am J Obstet Gynecol. 1956; 71: 759-63.
Bonney V. The technique and results of myomectomy. Lancet 1931; 220: 171-73.
Hee E, Lee PI, Huh CY, Kim DH, Lee BS, Lee JK, et al. Predictors of leiomyoma recurrence after laparoscopic myomectomy. J Min Inv Gynecol 2007; 14: 690-697.
Ribič-Pucelj M,Tomaževič T, Vogler A, Kobal B. Laparoskopska miomektomija- indikacije, tehnike in zapleti. Endoskopska revija 2000; 5: 77-82.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
